This contrasts with the effects of TGFβ inhibition in stimulating CD8+ T cell recruitment from the stroma to the tumor parenchyma, which has been observed in several tumor types (Chakravarthy et al. 2018, Mariathasan et al. 2018, Tauriello et al. 2018, Dodagatta-Marri et al. 2019, Gunderson et al. 2020). The gene discussed is CD8A; the disease is neoplasm.